Explore the words cloud of the RiboMed project. It provides you a very rough idea of what is the project "RiboMed" about.
The following table provides information about the project.
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
|Coordinator Country||Portugal [PT]|
|Total cost||799˙750 €|
|EC max contribution||799˙750 € (100%)|
1. H2020-EU.4.b. (Twinning of research institutions)
|Duration (year-month-day)||from 2019-09-01 to 2022-08-31|
Take a look of project's partnership.
|1||INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES||PT (LISBOA)||coordinator||424˙750.00|
|2||MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)||DE (BERLIN)||participant||125˙000.00|
|3||THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD||UK (OXFORD)||participant||125˙000.00|
|4||WEIZMANN INSTITUTE OF SCIENCE||IL (REHOVOT)||participant||125˙000.00|
The Instituto de Medicina Molecular João Lobo Antunes (iMM) ranks among the top research institutions in Portugal. However, the institute faces constraints related to reduced availability of national research funding and access to cutting-edge resources and scientific infrastructure. This twinning proposal (RiboMed) was set on the strategic vision of iMM to boost its recently enlarged community of young RNA researchers. In fact, while iMM has well-established communities working on neuroscience, immunology and infection, RNA biology is only now starting to expand as we recognize its centrality in human health. Our strategy includes: 1) Promoting scientific excellence through the implementation of joint research projects between iMM and the twinning partners. We will strengthen existing interactions and promote new collaborations through short-term staff exchanges, expert visits and joint lab retreats; 2) Nurturing a community of self-challenging and ambitious students and early-stage researchers at iMM by ensuring their early integration in international training and mentoring networks, facilitating conference attendance, and organizing summer schools, thematic courses and on-site training; 3) Raising international awareness of iMM through mobility of researchers, targeted dissemination and communication activities, and on-site organization of workshops and a major international conference; 4) Consolidating the innovation and entrepreneurship ecosystem at iMM through translation of basic findings into potential novel RNA biomarkers, RNA-based diagnostic assays and RNA therapeutic targets. We believe RiboMed is exceptionally timely, as it will allow the recently settled young RNA researchers to thrive at iMM. This, in turn, will place the institute in Lisbon within the core of European laboratories that are carrying on frontier research on how transcription and RNA processing shape and define the complexity of human disease.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "RIBOMED" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "RIBOMED" are provided by the European Opendata Portal: CORDIS opendata.